Multi<b>-</b>omics analysis reveals AFAP1L1 as a prognostic biomarker and immune<b>-</b>related therapeutic target in glioma. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue BanWei C, Wang A, Liu Z, Li D.
europepmc +1 more source
Clinical features of 28 cases of anti-leucine-rich glioma-inactivated protein 1 encephalitis and anti-contactin-associated protein-like 2 encephalitis. [PDF]
Zhong Nan Da Xue Xue Bao Yi Xue Ban, 2023 Feng J +5 more
europepmc +1 more source
[Establishment of an Engineered Bacterial Membrane Biomimetic Nanodrug Delivery System and Its Role in the Treatment of Glioma]. [PDF]
Sichuan Da Xue Xue Bao Yi Xue BanZhao Y +9 more
europepmc +1 more source
, 2001 一种由无机盐沉淀解胶制备氧化物溶胶的方法，其特征在于该方法以无机盐为原料，通过使用酸或碱溶液调节无机盐溶液的pH值至该氧化物的等电点附近，使其生成氢氧化合物沉淀，其沉淀物经过滤、洗涤除去杂质离子后，以酸作为解胶剂将pH值调节到等电点以下，解胶处理得到稳定的氧化物溶胶。利用本发明不仅可以制备大多数的单组分氧化物溶胶，而且可以制备多组分的混合氧化物溶胶。本发明制得的溶胶粒径小而分布单一，稳定性好，与传统的由醇盐水解法制得的溶胶在性质上相似，而相对的成本低廉，操作简单而易控制，更适宜于大规模生产 ...
杨维慎, 熊国兴, 张玉红, 姚楠
core
[Multimodal high-grade glioma semantic segmentation network with multi-scale and multi-attention fusion mechanism]. [PDF]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi, 2022 Wu Y, Lin L, Wu S.
europepmc +1 more source
Colla corii asini drink and preparation method thereof
, 2014 本发明公开一种阿胶饮料及其制备方法，以阿胶为主料，以菊粉、果粉、甜味剂等为辅料，依次经过原料预处理、熬煮、过滤、杀菌后得到阿胶-菊粉饮料；所述饮料配方为(质量分数)：阿胶：1-2%，菊粉：3-10%，木糖醇：3-5%，果粉：5-10%，甜菊糖：0.005%，余量为水。本发明的优点是：菊粉的加入不仅使阿胶饮料具有更佳的口味和口感，而且能够促进肠道有益菌的生长，促进常带蠕动，防止便秘的发生，有效地解决了阿胶存在的副作用问题。因此，本发明具有以下有益效果：(1)饮料饮用方便，适合各年龄阶段人群饮用；(2)口味、
徐兰兰 +4 more
core
[MiR-26-3p regulates proliferation, migration, invasion and apoptosis of glioma cells by targeting CREB1]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoHuang Q, Zhou J, Wang Z, Yang K, Chen Z.
europepmc +1 more source
[Establishment of a mouse model bearing orthotopic temozolomide-resistant glioma]. [PDF]
Nan Fang Yi Ke Da Xue Xue Bao, 2021 Shi L +8 more
europepmc +1 more source
[A predictive model for survival outcomes of glioma patients based on multi-parametric, multi-regional MRI radiomics features and clinical features]. [PDF]
Nan Fang Yi Ke Da Xue Xue BaoHuang X, Chen F, Zhang Y, Liang S.
europepmc +1 more source